11 march 2022
Corrigendum to: ‘A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers’ [J Hepatol 2022 (76) 275-282]
No abstract available
Erratum for
-
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.J Hepatol. 2022 Feb;76(2):275-282. doi: 10.1016/j.jhep.2021.10.005. Epub 2021 Oct 14.PMID: 34656649
Additional Info
-
Authors
Darlay R.; Perney P.; Mullhaupt B.; Mathurin P.; Botwin G.; Thursz M. R.; Mueller S.; Haber P. S.; Trepo E.; Aithal G. P.; Seitz H. K.; Eyer F.; Day C. P.; Gleeson D.; Daly A. K.; Thompson A.; Cordell H. J.; Soyka M.; Whitfield J. B.; Goldman D.; Morgan T. R.; Masson S.; Liang T.; Seth D.; Moreno C.; Pirmohamed M.; Genom A. L. C. Consortium; Liangpunsakul S.; Nalpas B.; Atkinson S. R.; Nagy L. E.; Jacquet J. M.; Chalasani N. P.; Bataller R.; Moirand R.; Foroud T.; Stickel F.; Nahon P.; McQuillin A.; Schwantes-An T. H.; Naveau S.; Morgan M. Y. -
Issue
J Hepatol . 2022 Mar 11;S0168-8278(22)00117-9 -
Published Date
11 march 2022
Related items
- Moderate consumption of a polyphenolic-enriched wine attenuates alcohol-associated alterations in hepatic biomarkers in overweight subjects: a randomized clinical trial
- Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysis
- Special Population: A Global Perspective on Metabolic Dysfunction-Associated Alcohol-Related Liver Disease
- Moderate alcohol consumption and clinical outcomes in MASLD: a systematic review and meta-analysis of longitudinal cohorts
- Is light-to-moderate alcohol drinking associated with the onset of metabolic dysfunction-associated steatotic liver disease in a Chinese cohort?